Pretty impressive result given the current economic environment.
Strong cash position with no debt and strong growth across key metrics - imo this should be worth double the current market cap
- Forums
- ASX - By Stock
- NXL
- Ann: FY23 Preliminary Results Update
Ann: FY23 Preliminary Results Update, page-2
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.38 |
Change
-0.120(3.43%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
$3.47 | $3.52 | $3.37 | $2.297M | 668.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
53 | 17936 | $3.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.38 | 1124 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
46 | 23820 | 3.370 |
19 | 6791 | 3.360 |
14 | 35633 | 3.350 |
5 | 4569 | 3.340 |
6 | 6152 | 3.330 |
Price($) | Vol. | No. |
---|---|---|
3.380 | 2574 | 6 |
3.390 | 10731 | 12 |
3.400 | 15458 | 10 |
3.410 | 11436 | 8 |
3.420 | 21240 | 8 |
Last trade - 15.31pm 15/07/2024 (20 minute delay) ? |
Featured News
NXL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online